Page last updated: 2024-12-05

adenosine diphosphate glucose

Description

Adenosine Diphosphate Glucose: Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ADP alpha-D-glucoside(2-) : A nucleotide-sugar oxoanion resutling from the deprotonation of both free OH groups of the diphosphate group of ADP alpha-D-glucoside. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID42609821
CHEBI ID57498
MeSH IDM0000382

Synonyms (8)

Synonym
ADP-D-GLUCOSE ,
adenosine diphosphate glucose
adp-alpha-d-glucose
adp alpha-d-glucoside dianion
adenosine 5'-[3-(alpha-d-glucopyranosyl) diphosphate]
adp alpha-d-glucoside(2-)
CHEBI:57498
Q27124737
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
NDP-alpha-D-glucose(2-)A nucleotide-sugar oxoanion obtained by deprotonation of the diphosphate OH groups of any NDP-alpha-D-glucose; major species at pH 7.3.
ribonucleoside 5'-diphosphate-alpha-D-glucose(2-)A nucleotide-sugar oxoanion obtained by deprotonation of the diphosphate OH groups of any ribonucleoside 5'-diphosphate-alpha-D-glucose. Major microspecies at pH 7.3
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (143)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (34.27)18.7374
1990's19 (13.29)18.2507
2000's46 (32.17)29.6817
2010's24 (16.78)24.3611
2020's5 (3.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews11 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other132 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com